Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
4.890
-0.200 (-3.93%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $17.86 million as of September 18, 2025. Its market cap has increased by 136.23% in one year.
Market Cap
17.86M
Enterprise Value
12.03M
1-Year Change
136.23%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $17.86M, a decrease of -89.23%. That is a compound annual growth rate of -19.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 17.86M | -29.94% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | 40.94M | 138.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |